Bryan Wells

ORCID: 0000-0001-9994-7947
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal and Vascular Pathologies
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiovascular Issues in Pregnancy
  • Blood Pressure and Hypertension Studies
  • Cardiac Structural Anomalies and Repair
  • Peripheral Artery Disease Management
  • Vascular anomalies and interventions
  • Cardiac Health and Mental Health
  • Coronary Artery Anomalies
  • Abdominal vascular conditions and treatments
  • Breast Cancer Treatment Studies
  • Venous Thromboembolism Diagnosis and Management
  • COVID-19 Clinical Research Studies
  • Hemodynamic Monitoring and Therapy
  • Coronary Interventions and Diagnostics
  • Mechanical Circulatory Support Devices
  • Cardiac Valve Diseases and Treatments
  • Cardiac, Anesthesia and Surgical Outcomes
  • Aortic aneurysm repair treatments
  • Cardiovascular Function and Risk Factors
  • Global Cancer Incidence and Screening
  • Sodium Intake and Health
  • Breast Lesions and Carcinomas
  • Colorectal and Anal Carcinomas
  • Heart Rate Variability and Autonomic Control

Emory University
2015-2025

Emory and Henry College
2018-2024

American Society of Echocardiography
2024

Littelfuse (United States)
2024

Beth Israel Deaconess Hospital
2024

Hope Heart Institute
2024

Providence College
2024

Radiance Technologies (United States)
2022-2023

Dartmouth–Hitchcock Medical Center
2023

Emory University Hospital
2023

10.1016/s0140-6736(18)31082-1 article EN The Lancet 2018-05-23

10.1016/s0140-6736(21)00788-1 article EN The Lancet 2021-05-16
David E. Kandzari Raymond R. Townsend Kazuomi Kario Felix Mahfoud Michael A. Weber and 95 more Roland E. Schmieder Stuart J. Pocock Konstantinos Tsioufis D. Konstantinidis James W. Choi Cara East Lucas Lauder Debbie L. Cohen Taisei Kobayashi Axel Schmid David P. Lee Adrian Ma Joachim Weil Tolga Agdirlioglu Markus P. Schlaich Sharad Shetty Chandan Devireddy Janice P. Lea Jiro Aoki Andrew S.P. Sharp Richard Anderson Martin Fahy Vanessa DeBruin Sandeep Brar Michael Böhm Yale Wang Desmond Jay Brent McLaurin Carl Lomboy Suhail Allaqaband Fuad Jan Bharat Gummadi Marc R. Litt Fidel Garcia Jasvindar Singh Angela L. Brown James W. Choi Ashley Paul Andrew S.P. Sharp James Coulson Aravinda Nanjundappa Ganpat G. Thakker James Campbell Benjamin Honton Bruno Farah Manesh R. Patel Antonio Gutiérrez Crystal C. Tyson Laura P. Svetkey Marat Fudim Neha J. Pagidipati Schuyler Jones Sreekanth Vemulapalli Chandan Devireddy Ambar Kulshreshtha Bryan Wells Janice P. Lea Bryan Batson Robert B. Wilkins Faisal Sharif Abdullahi Mohamed Khair Abhishek Wilson Pallippattu Aishah Alhmoudi Brian Gaffney Christian Cawley Colin Gorry Hanan Hamed Jennifer Carron John Birrane Liesbeth Rosseel Mattia Lunardi Michael J. Cronin Myles McKittrick Naeif Almagal Noman Khalid Qussai Shehahd Shirjeel Shahzad Simone Fezzi Stanislav Tyulkin Xavier Armario Sanjit S. Jolly Gordon Yip Jon-David Schwalm Michael Tsang Shamir R. Mehta Philipp Lurz Christian Binner Danilo Obradović Florian Fahr Ines Richter Johannes Rotta detto Loria Karl Fengler Karl‐Philipp Rommel Mateo Marin‐Cuartas Matthias Lerche

Renal denervation (RDN) reduces blood pressure (BP) in patients with uncontrolled hypertension the absence of antihypertensive medications.

10.1016/j.jacc.2023.08.045 article EN cc-by-nc-nd Journal of the American College of Cardiology 2023-10-30

Ultrasound renal denervation (uRDN) was shown to lower blood pressure (BP) in patients with uncontrolled hypertension (HTN). Establishing the magnitude and consistency of uRDN effect across HTN spectrum is clinically important.

10.1001/jamacardio.2023.0338 article EN cc-by-nc-nd JAMA Cardiology 2023-02-28
Michel Azizi Roland E. Schmieder Felix Mahfoud Michael A. Weber Joost Daemen and 95 more Melvin D. Lobo Andrew S.P. Sharp Michael J. Bloch Jan Basile Yale Wang Manish Saxena Philipp Lurz Florian Rader Jeremy Sayer Naomi D.L. Fisher David Fouassier Neil C. Barman Helen Reeve-Stoffer Candace K. McClure Ajay J. Kirtane Desmond Jay Nedaa Skeik Robert S. Schwartz Suhail Dohad Ronald G. Victor Kintur Sanghvi Josh Costello Courtney Walsh Josephine Abraham Theophilus Owan Anu Abraham Laura Mauri Piotr Sobieszczky Jonathan S. Williams Chanwit Roongsritong Thomas M. Todoran Eric R. Powers Emily Hodskins Pete Fong Cheryl L. Laffer James S. Gainer Mark Robbins John P. Reilly Michael Cash Jessie Goldman Sandeep Aggarwal Gary S. Ledley David His Scott D. Martin Edward L. Portnay David A. Calhoun Thomas McElderry William Maddox Suzanne Oparil Pei-Hsiu Huang Powell Jose Matheen Khuddus Suzanne Zentko James O’Meara Ilie Barb Joseph M. Garasic Doug Drachman Randy Zusman Kenneth Rosenfield Chandan Devireddy Janice P. Lea Bryan Wells Rick Stouffer Alan L. Hinderliter Eric Pauley Srinivasa Potluri Scott Biedermann Sripal Bangalore Stephen Williams David Zidar Mehdi H. Shishehbor Barry Effron Marco Costa Jai Radhakrishnan Anthony Mathur Ajay Jain Sudha Ganesh Iyer Nicholas Robinson Sadat Ali Edroos Terry Levy Amit Patel David Beckett Clare Bent Justin E. Davies Neil Chapman Matthew Shun Shin James P. Howard Anil Joseph Richard D’Souza Robert Gerber Mohamad Faris Andrew John Marshall Cristina Elorz Robert Höllriegel Karl Fengler

Background: The multicenter, international, randomized, blinded, sham-controlled RADIANCE-HTN SOLO trial (A Study of the ReCor Medical Paradise System in Clinical Hypertension) demonstrated a 6.3 mm Hg greater reduction daytime ambulatory systolic blood pressure (BP) at 2 months by endovascular ultrasound renal denervation (RDN) compared with sham procedure among patients not treated antihypertensive medications. We report 6-month results after addition recommended standardized stepped-care...

10.1161/circulationaha.119.040451 article EN Circulation 2019-03-17
Michel Azizi Felix Mahfoud Michael A. Weber Andrew Sharp Roland E. Schmieder and 95 more Philipp Lurz Melvin D. Lobo Naomi D.L. Fisher Joost Daemen Michael J. Bloch Jan Basile Kintur Sanghvi Manish Saxena Philippe Gosse J. Stephen Jenkins Terry Levy Alexandre Persu Benjamin Kably Lisa Claude Helen Reeve-Stoffer Candace K. McClure Ajay J. Kirtane Christopher M. Mullin Lisa Thackeray Glenn M. Chertow Thomas Kahan Harold Dauerman Steven Ullery J. Dawn Abbott Andreas Loening Ron Zagoria John Costello Courtney Krathan Luot Lewis Andrew McElvarr John P. Reilly Michael Cash Shannon Williams Maria Jarvis Pete Fong Cheryl L. Laffer James S. Gainer Mark Robbins Sherron Crook Sarita Maddel David H. Hsi Scott D. Martin Edward L. Portnay Maryanne Ducey Suzanne Rose Elizabeth DelMastro Sripal Bangalore Stephen Williams Stanley Cabos Carolina Rodríguez Álvarez Thomas M. Todoran Eric R. Powers Emily Hodskins Vijay Paladugu Anna Tecklenburg Chandan Devireddy Janice P. Lea Bryan Wells Amanda Fiebach Claudia Merlin Florian Rader Suhail Dohad H. Mike Kim Mohammad H. Rashid Josephine Abraham Theophilus Owan Anu Abraham Iran Lavasani Hailey Neilson David A. Calhoun Thomas McElderry William Maddox Suzanne Oparil Sheila Kinder Jai Radhakrishnan Candido Batres Suzanne Edwards Joseph M. Garasic Doug Drachman Randy Zusman Kenneth Rosenfield Danny Do Matheen Khuddus Suzanne Zentko James O’Meara Ilie Barb Abby Foster Alice Boyette Yale Wang Desmond Jay Nedaa Skeik Robert S. Schwartz Rose Peterson Jo Anne Goldman Jessie Goldman

Importance Although early trials of endovascular renal denervation (RDN) for patients with resistant hypertension (RHTN) reported inconsistent results, ultrasound RDN (uRDN) was found to decrease blood pressure (BP) vs sham at 2 months in RHTN taking stable background medications the Study ReCor Medical Paradise System Clinical Hypertension (RADIANCE-HTN TRIO) trial. Objectives To report prespecified analysis persistence BP effects and safety uRDN 6 conjunction escalating antihypertensive...

10.1001/jamacardio.2022.3904 article EN cc-by-nc-nd JAMA Cardiology 2022-11-09

This study utilized a transgenic mouse model that expresses an inducible dominant-negative mutation of the transforming growth factor (TGF)-beta type II receptor (DnTGFbetaRII) to define structural and functional responses left ventricle (LV) pressure-overload stress in absence intact TGF-beta signaling cascade. DnTGFbetaRII nontransgenic (NTG) control mice (male, 8-10 wk) were randomized receive Zn(2+) (25 mM ZnSO(4) drinking H(2)O induce gene expression) or tap then further undergo...

10.1152/ajpheart.00529.2009 article EN AJP Heart and Circulatory Physiology 2009-11-20

Background Myocardial infarction secondary to spontaneous coronary artery dissection (SCAD) can be traumatic and potentially trigger posttraumatic stress disorder (PTSD). In a large, multicenter, registry‐based cohort, we documented prevalence of lifetime past‐month SCAD‐induced PTSD, as well related treatment seeking, examined range health‐relevant correlates PTSD. Methods Results Patients with SCAD were enrolled in the iSCAD (International SCAD) Registry. At baseline, site investigators...

10.1161/jaha.123.032819 article EN cc-by-nc-nd Journal of the American Heart Association 2024-03-27

Introduction: Spontaneous coronary artery dissection (SCAD) is a nonatherosclerotic cause of myocardial infarction. Migraine headache has been reported to be common among patients with SCAD, but the degree migraine-related disability not quantified. Methods: Clinical data and variables were obtained from baseline assessment prospective, multicenter iSCAD Registry. Migraine-related was quantified using self-reported Disability Assessment (MIDAS). Demographic, clinical, psychosocial, medical...

10.1177/1358863x241252444 article EN cc-by-nc Vascular Medicine 2024-06-01

Diabetes is associated with increased risk for complications following coronary bypass grafting (CABG) surgery. Augmented superoxide \((^{{\cdot}}\mathrm{O}_{2}^{{\bar{{\cdot}}}})\) production plays an important role in diabetic by causing vascular dysfunction. The potent vasoconstrictor endothelin-1 (ET-1) also elevated diabetes and CABG; however, the effect of ET-1 on \(^{{\cdot}}\mathrm{O}_{2}^{{\bar{{\cdot}}}}\) generation and/or dysfunction conduits remain unknown. Accordingly, this...

10.1124/jpet.104.078105 article EN Journal of Pharmacology and Experimental Therapeutics 2004-12-17

There is no gold standard for the measurement of pulmonary regurgitation (PR) severity. Two‐dimensional (2D) transthoracic echocardiography most commonly used to quantify PR severity using color Doppler criteria aortic regurgitation. However, this method limited by visualization only one or two dimensions proximal jet vena contracta (VC) precluding accurate assessment its shape size. This limitation would be expected obviated three‐dimensional (3D) echocardiography, which could provide a...

10.1111/j.1540-8175.2008.00721.x article EN Echocardiography 2008-09-01

Craniocervical fibromuscular dysplasia (FMD) is associated with dissections and S-shaped curves in the internal carotid artery (ICA). We evaluated occurrence of S-curves patients presenting acute strokes due to ICA steno-occlusive dissections.This was a retrospective review interventional databases two academic tertiary-care institutions. The presence curves, C-shaped 360-degree loops, as well classic FMD atherosclerotic changes at bulb curve/loop determined. Cases were compared control...

10.1159/000447978 article EN Interventional Neurology 2016-01-01

Fibromuscular dysplasia (FMD) is a nonatherosclerotic arterial disease that predominately affects women and most commonly diagnosed in middle age. The natural history of FMD among patients at an older age not well understood.To examine the differences clinical presentation, bed involvement, vascular events, need for procedures between younger with FMD.Analysis baseline data enrolled US Registry as December 15, 2016, referral centers participating FMD. Patients 18 years time enrollment those...

10.1001/jamacardio.2018.1638 article EN JAMA Cardiology 2018-06-20

10.1007/s11936-010-0081-x article EN Current Treatment Options in Cardiovascular Medicine 2010-06-07
Coming Soon ...